When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CLRB - Cellectar Biosciences: A Shoestring Opportunity You're About To Miss
Cellectar Biosciences Inc.
2024-02-12 01:34:26 ET
Summary
Cellectar Biosciences is a developmental biotech focused on a radiolabeled phospholipid for hematologic malignancies, with a focus on Waldenstrom's macroglobulinemia.
Their most advanced development is in Waldenstrom's, with positive trial results and plans to file for Accelerated Approval.
The company has a strong chance at approval but faces cash concerns and the challenge of a small market size for its drug.